nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCC1—Progesterone—uterine cancer	0.136	0.159	CbGbCtD
Erythromycin—ABCC1—Dactinomycin—uterine cancer	0.108	0.126	CbGbCtD
Erythromycin—ABCC1—Epirubicin—uterine cancer	0.0783	0.0915	CbGbCtD
Erythromycin—CYP3A7—Progesterone—uterine cancer	0.0674	0.0788	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0674	0.0788	CbGbCtD
Erythromycin—ABCC1—Etoposide—uterine cancer	0.061	0.0713	CbGbCtD
Erythromycin—CYP3A5—Progesterone—uterine cancer	0.0505	0.0591	CbGbCtD
Erythromycin—ABCC1—Doxorubicin—uterine cancer	0.0416	0.0487	CbGbCtD
Erythromycin—CYP1A2—Progesterone—uterine cancer	0.0376	0.044	CbGbCtD
Erythromycin—ABCB1—Progesterone—uterine cancer	0.0329	0.0385	CbGbCtD
Erythromycin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0298	0.0348	CbGbCtD
Erythromycin—ABCB1—Dactinomycin—uterine cancer	0.0261	0.0305	CbGbCtD
Erythromycin—CYP3A5—Etoposide—uterine cancer	0.0226	0.0264	CbGbCtD
Erythromycin—CYP3A4—Progesterone—uterine cancer	0.0197	0.023	CbGbCtD
Erythromycin—CYP2B6—Doxorubicin—uterine cancer	0.0196	0.0229	CbGbCtD
Erythromycin—CYP1A2—Etoposide—uterine cancer	0.0168	0.0197	CbGbCtD
Erythromycin—ABCB1—Etoposide—uterine cancer	0.0147	0.0172	CbGbCtD
Erythromycin—ABCB1—Doxorubicin—uterine cancer	0.01	0.0117	CbGbCtD
Erythromycin—CYP3A4—Etoposide—uterine cancer	0.00882	0.0103	CbGbCtD
Erythromycin—MLNR—smooth muscle tissue—uterine cancer	0.00848	0.362	CbGeAlD
Erythromycin—CYP3A4—Doxorubicin—uterine cancer	0.00602	0.00703	CbGbCtD
Erythromycin—Redness—Progesterone—uterine cancer	0.00285	0.0265	CcSEcCtD
Erythromycin—Electrocardiogram QT prolonged—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.0252	CcSEcCtD
Erythromycin—Nephritis interstitial—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.024	CcSEcCtD
Erythromycin—Tubulointerstitial nephritis—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.0211	CcSEcCtD
Erythromycin—Eruption—Dactinomycin—uterine cancer	0.00221	0.0205	CcSEcCtD
Erythromycin—Tenderness—Progesterone—uterine cancer	0.00221	0.0205	CcSEcCtD
Erythromycin—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.002	0.0185	CcSEcCtD
Erythromycin—Hepatotoxicity—Dactinomycin—uterine cancer	0.00176	0.0163	CcSEcCtD
Erythromycin—Hepatic function abnormal—Progesterone—uterine cancer	0.0016	0.0148	CcSEcCtD
Erythromycin—Sensitisation—Epirubicin—uterine cancer	0.00155	0.0143	CcSEcCtD
Erythromycin—Injury—Progesterone—uterine cancer	0.00152	0.0141	CcSEcCtD
Erythromycin—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.0134	CcSEcCtD
Erythromycin—Sensitisation—Doxorubicin—uterine cancer	0.00143	0.0133	CcSEcCtD
Erythromycin—SLC22A7—renal system—uterine cancer	0.00135	0.0574	CbGeAlD
Erythromycin—Irritability—Progesterone—uterine cancer	0.00133	0.0124	CcSEcCtD
Erythromycin—Liver function test abnormal—Progesterone—uterine cancer	0.00129	0.012	CcSEcCtD
Erythromycin—Hepatotoxicity—Etoposide—uterine cancer	0.00128	0.0118	CcSEcCtD
Erythromycin—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.0112	CcSEcCtD
Erythromycin—Abdominal discomfort—Progesterone—uterine cancer	0.00116	0.0107	CcSEcCtD
Erythromycin—Pain—Carboplatin—uterine cancer	0.00112	0.0104	CcSEcCtD
Erythromycin—Jaundice—Progesterone—uterine cancer	0.00105	0.00974	CcSEcCtD
Erythromycin—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00973	CcSEcCtD
Erythromycin—Hepatitis—Progesterone—uterine cancer	0.000967	0.00897	CcSEcCtD
Erythromycin—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.000952	0.00882	CcSEcCtD
Erythromycin—Skin exfoliation—Etoposide—uterine cancer	0.000941	0.00872	CcSEcCtD
Erythromycin—ABCC1—myometrium—uterine cancer	0.000919	0.0392	CbGeAlD
Erythromycin—Erythema multiforme—Progesterone—uterine cancer	0.000914	0.00848	CcSEcCtD
Erythromycin—Liver function test abnormal—Dactinomycin—uterine cancer	0.000912	0.00846	CcSEcCtD
Erythromycin—Tinnitus—Progesterone—uterine cancer	0.000902	0.00836	CcSEcCtD
Erythromycin—Eruption—Epirubicin—uterine cancer	0.000898	0.00832	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00089	0.00825	CcSEcCtD
Erythromycin—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000876	0.00813	CcSEcCtD
Erythromycin—Erythema—Progesterone—uterine cancer	0.000842	0.00781	CcSEcCtD
Erythromycin—Eruption—Doxorubicin—uterine cancer	0.000831	0.0077	CcSEcCtD
Erythromycin—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000829	0.00768	CcSEcCtD
Erythromycin—Redness—Epirubicin—uterine cancer	0.000818	0.00759	CcSEcCtD
Erythromycin—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.000817	0.00758	CcSEcCtD
Erythromycin—SLCO1A2—renal system—uterine cancer	0.000815	0.0347	CbGeAlD
Erythromycin—Burning sensation—Epirubicin—uterine cancer	0.000795	0.00737	CcSEcCtD
Erythromycin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000763	0.00707	CcSEcCtD
Erythromycin—Redness—Doxorubicin—uterine cancer	0.000757	0.00702	CcSEcCtD
Erythromycin—Vertigo—Progesterone—uterine cancer	0.000756	0.00701	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.000755	0.007	CcSEcCtD
Erythromycin—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.000747	0.00693	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Epirubicin—uterine cancer	0.000746	0.00692	CcSEcCtD
Erythromycin—Palpitations—Progesterone—uterine cancer	0.000744	0.0069	CcSEcCtD
Erythromycin—Burning sensation—Doxorubicin—uterine cancer	0.000735	0.00682	CcSEcCtD
Erythromycin—Convulsion—Progesterone—uterine cancer	0.000729	0.00676	CcSEcCtD
Erythromycin—Chest pain—Progesterone—uterine cancer	0.000717	0.00665	CcSEcCtD
Erythromycin—ABCC1—uterine cervix—uterine cancer	0.000715	0.0305	CbGeAlD
Erythromycin—Discomfort—Progesterone—uterine cancer	0.000708	0.00657	CcSEcCtD
Erythromycin—Confusional state—Progesterone—uterine cancer	0.000693	0.00642	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.00069	0.0064	CcSEcCtD
Erythromycin—Anaphylactic shock—Progesterone—uterine cancer	0.000687	0.00637	CcSEcCtD
Erythromycin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.000685	0.00636	CcSEcCtD
Erythromycin—Hepatitis—Dactinomycin—uterine cancer	0.000684	0.00634	CcSEcCtD
Erythromycin—ABCC1—decidua—uterine cancer	0.000681	0.029	CbGeAlD
Erythromycin—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000674	0.00625	CcSEcCtD
Erythromycin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000661	0.00613	CcSEcCtD
Erythromycin—Anorexia—Progesterone—uterine cancer	0.000655	0.00607	CcSEcCtD
Erythromycin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000649	0.00602	CcSEcCtD
Erythromycin—ABCC1—endometrium—uterine cancer	0.000646	0.0276	CbGeAlD
Erythromycin—Erythema multiforme—Dactinomycin—uterine cancer	0.000646	0.00599	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000644	0.00597	CcSEcCtD
Erythromycin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000642	0.00595	CcSEcCtD
Erythromycin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000628	0.00582	CcSEcCtD
Erythromycin—ABCC1—mammalian vulva—uterine cancer	0.000625	0.0267	CbGeAlD
Erythromycin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000623	0.00577	CcSEcCtD
Erythromycin—Decreased appetite—Progesterone—uterine cancer	0.000597	0.00554	CcSEcCtD
Erythromycin—ABCC1—uterus—uterine cancer	0.000596	0.0254	CbGeAlD
Erythromycin—Erythema—Dactinomycin—uterine cancer	0.000595	0.00552	CcSEcCtD
Erythromycin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000593	0.0055	CcSEcCtD
Erythromycin—Pain—Progesterone—uterine cancer	0.000588	0.00545	CcSEcCtD
Erythromycin—Feeling abnormal—Progesterone—uterine cancer	0.000566	0.00525	CcSEcCtD
Erythromycin—Gastrointestinal pain—Progesterone—uterine cancer	0.000562	0.00521	CcSEcCtD
Erythromycin—Ventricular tachycardia—Epirubicin—uterine cancer	0.000552	0.00512	CcSEcCtD
Erythromycin—CYP3A5—uterine cervix—uterine cancer	0.000549	0.0234	CbGeAlD
Erythromycin—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000546	0.00507	CcSEcCtD
Erythromycin—Urticaria—Progesterone—uterine cancer	0.000546	0.00506	CcSEcCtD
Erythromycin—Abdominal pain—Progesterone—uterine cancer	0.000543	0.00504	CcSEcCtD
Erythromycin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000541	0.00502	CcSEcCtD
Erythromycin—Jaundice—Etoposide—uterine cancer	0.000537	0.00498	CcSEcCtD
Erythromycin—CYP1A2—renal system—uterine cancer	0.000533	0.0227	CbGeAlD
Erythromycin—Skin exfoliation—Epirubicin—uterine cancer	0.000527	0.00489	CcSEcCtD
Erythromycin—CYP3A5—renal system—uterine cancer	0.000514	0.0219	CbGeAlD
Erythromycin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000513	0.00476	CcSEcCtD
Erythromycin—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000511	0.00474	CcSEcCtD
Erythromycin—CYP2B6—renal system—uterine cancer	0.000511	0.0218	CbGeAlD
Erythromycin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000509	0.00472	CcSEcCtD
Erythromycin—Hypersensitivity—Progesterone—uterine cancer	0.000506	0.00469	CcSEcCtD
Erythromycin—Discomfort—Dactinomycin—uterine cancer	0.000501	0.00464	CcSEcCtD
Erythromycin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000495	0.00459	CcSEcCtD
Erythromycin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000492	0.00456	CcSEcCtD
Erythromycin—Skin exfoliation—Doxorubicin—uterine cancer	0.000488	0.00452	CcSEcCtD
Erythromycin—ABCC1—female gonad—uterine cancer	0.000487	0.0208	CbGeAlD
Erythromycin—Pruritus—Progesterone—uterine cancer	0.000486	0.00451	CcSEcCtD
Erythromycin—ABCC1—vagina—uterine cancer	0.000484	0.0206	CbGeAlD
Erythromycin—Diarrhoea—Progesterone—uterine cancer	0.00047	0.00436	CcSEcCtD
Erythromycin—Erythema multiforme—Etoposide—uterine cancer	0.000468	0.00434	CcSEcCtD
Erythromycin—Anorexia—Dactinomycin—uterine cancer	0.000463	0.00429	CcSEcCtD
Erythromycin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000459	0.00425	CcSEcCtD
Erythromycin—Hepatic function abnormal—Epirubicin—uterine cancer	0.000459	0.00425	CcSEcCtD
Erythromycin—Dizziness—Progesterone—uterine cancer	0.000454	0.00421	CcSEcCtD
Erythromycin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00044	0.00408	CcSEcCtD
Erythromycin—Vomiting—Progesterone—uterine cancer	0.000437	0.00405	CcSEcCtD
Erythromycin—Rash—Progesterone—uterine cancer	0.000433	0.00402	CcSEcCtD
Erythromycin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000426	0.00395	CcSEcCtD
Erythromycin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000424	0.00394	CcSEcCtD
Erythromycin—Decreased appetite—Dactinomycin—uterine cancer	0.000422	0.00391	CcSEcCtD
Erythromycin—Dysgeusia—Etoposide—uterine cancer	0.000422	0.00391	CcSEcCtD
Erythromycin—Pain—Dactinomycin—uterine cancer	0.000415	0.00385	CcSEcCtD
Erythromycin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000412	0.00382	CcSEcCtD
Erythromycin—CYP2B6—female reproductive system—uterine cancer	0.000409	0.0174	CbGeAlD
Erythromycin—Nausea—Progesterone—uterine cancer	0.000408	0.00378	CcSEcCtD
Erythromycin—Feeling abnormal—Dactinomycin—uterine cancer	0.0004	0.00371	CcSEcCtD
Erythromycin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000397	0.00368	CcSEcCtD
Erythromycin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000396	0.00367	CcSEcCtD
Erythromycin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.00364	CcSEcCtD
Erythromycin—Vertigo—Etoposide—uterine cancer	0.000387	0.00359	CcSEcCtD
Erythromycin—CYP3A4—renal system—uterine cancer	0.000386	0.0164	CbGeAlD
Erythromycin—Abdominal pain—Dactinomycin—uterine cancer	0.000384	0.00356	CcSEcCtD
Erythromycin—ABCB1—myometrium—uterine cancer	0.000375	0.016	CbGeAlD
Erythromycin—CYP3A5—female gonad—uterine cancer	0.000374	0.016	CbGeAlD
Erythromycin—Convulsion—Etoposide—uterine cancer	0.000373	0.00346	CcSEcCtD
Erythromycin—CYP3A5—vagina—uterine cancer	0.000372	0.0159	CbGeAlD
Erythromycin—Liver function test abnormal—Epirubicin—uterine cancer	0.00037	0.00343	CcSEcCtD
Erythromycin—CYP2B6—vagina—uterine cancer	0.00037	0.0158	CbGeAlD
Erythromycin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00037	0.00343	CcSEcCtD
Erythromycin—Chest pain—Etoposide—uterine cancer	0.000367	0.0034	CcSEcCtD
Erythromycin—Discomfort—Etoposide—uterine cancer	0.000362	0.00336	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000361	0.00335	CcSEcCtD
Erythromycin—Hypersensitivity—Dactinomycin—uterine cancer	0.000358	0.00332	CcSEcCtD
Erythromycin—Confusional state—Etoposide—uterine cancer	0.000354	0.00329	CcSEcCtD
Erythromycin—Anaphylactic shock—Etoposide—uterine cancer	0.000351	0.00326	CcSEcCtD
Erythromycin—Liver function test abnormal—Doxorubicin—uterine cancer	0.000342	0.00318	CcSEcCtD
Erythromycin—Pancreatitis—Epirubicin—uterine cancer	0.00034	0.00315	CcSEcCtD
Erythromycin—Anorexia—Etoposide—uterine cancer	0.000335	0.00311	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000334	0.0031	CcSEcCtD
Erythromycin—Diarrhoea—Dactinomycin—uterine cancer	0.000332	0.00308	CcSEcCtD
Erythromycin—Pancreatitis—Doxorubicin—uterine cancer	0.000314	0.00291	CcSEcCtD
Erythromycin—ABCC1—lymph node—uterine cancer	0.000313	0.0134	CbGeAlD
Erythromycin—CYP3A4—female reproductive system—uterine cancer	0.000309	0.0132	CbGeAlD
Erythromycin—Vomiting—Dactinomycin—uterine cancer	0.000309	0.00286	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000306	0.00284	CcSEcCtD
Erythromycin—Rash—Dactinomycin—uterine cancer	0.000306	0.00284	CcSEcCtD
Erythromycin—Decreased appetite—Etoposide—uterine cancer	0.000306	0.00283	CcSEcCtD
Erythromycin—Jaundice—Epirubicin—uterine cancer	0.000301	0.00279	CcSEcCtD
Erythromycin—Pain—Etoposide—uterine cancer	0.000301	0.00279	CcSEcCtD
Erythromycin—ABCB1—epithelium—uterine cancer	0.000294	0.0125	CbGeAlD
Erythromycin—ABCB1—uterine cervix—uterine cancer	0.000292	0.0124	CbGeAlD
Erythromycin—Feeling abnormal—Etoposide—uterine cancer	0.00029	0.00269	CcSEcCtD
Erythromycin—Nausea—Dactinomycin—uterine cancer	0.000288	0.00267	CcSEcCtD
Erythromycin—Gastrointestinal pain—Etoposide—uterine cancer	0.000287	0.00266	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000283	0.00263	CcSEcCtD
Erythromycin—Urticaria—Etoposide—uterine cancer	0.000279	0.00259	CcSEcCtD
Erythromycin—Jaundice—Doxorubicin—uterine cancer	0.000279	0.00258	CcSEcCtD
Erythromycin—ABCB1—decidua—uterine cancer	0.000278	0.0119	CbGeAlD
Erythromycin—Abdominal pain—Etoposide—uterine cancer	0.000278	0.00258	CcSEcCtD
Erythromycin—Hepatitis—Epirubicin—uterine cancer	0.000277	0.00257	CcSEcCtD
Erythromycin—ABCB1—renal system—uterine cancer	0.000273	0.0116	CbGeAlD
Erythromycin—ABCB1—endometrium—uterine cancer	0.000264	0.0112	CbGeAlD
Erythromycin—Erythema multiforme—Epirubicin—uterine cancer	0.000262	0.00243	CcSEcCtD
Erythromycin—Hypersensitivity—Etoposide—uterine cancer	0.000259	0.0024	CcSEcCtD
Erythromycin—Tinnitus—Epirubicin—uterine cancer	0.000259	0.0024	CcSEcCtD
Erythromycin—Hepatitis—Doxorubicin—uterine cancer	0.000257	0.00238	CcSEcCtD
Erythromycin—ABCB1—mammalian vulva—uterine cancer	0.000255	0.0109	CbGeAlD
Erythromycin—Pruritus—Etoposide—uterine cancer	0.000249	0.00231	CcSEcCtD
Erythromycin—Arrhythmia—Epirubicin—uterine cancer	0.000248	0.0023	CcSEcCtD
Erythromycin—ABCB1—uterus—uterine cancer	0.000243	0.0104	CbGeAlD
Erythromycin—Erythema multiforme—Doxorubicin—uterine cancer	0.000243	0.00225	CcSEcCtD
Erythromycin—Erythema—Epirubicin—uterine cancer	0.000241	0.00224	CcSEcCtD
Erythromycin—Diarrhoea—Etoposide—uterine cancer	0.00024	0.00223	CcSEcCtD
Erythromycin—Tinnitus—Doxorubicin—uterine cancer	0.000239	0.00222	CcSEcCtD
Erythromycin—Dysgeusia—Epirubicin—uterine cancer	0.000236	0.00219	CcSEcCtD
Erythromycin—Dizziness—Etoposide—uterine cancer	0.000232	0.00216	CcSEcCtD
Erythromycin—Arrhythmia—Doxorubicin—uterine cancer	0.000229	0.00213	CcSEcCtD
Erythromycin—Vomiting—Etoposide—uterine cancer	0.000223	0.00207	CcSEcCtD
Erythromycin—Erythema—Doxorubicin—uterine cancer	0.000223	0.00207	CcSEcCtD
Erythromycin—Rash—Etoposide—uterine cancer	0.000222	0.00205	CcSEcCtD
Erythromycin—Dysgeusia—Doxorubicin—uterine cancer	0.000219	0.00203	CcSEcCtD
Erythromycin—ABCB1—female reproductive system—uterine cancer	0.000219	0.00932	CbGeAlD
Erythromycin—Vertigo—Epirubicin—uterine cancer	0.000217	0.00201	CcSEcCtD
Erythromycin—Palpitations—Epirubicin—uterine cancer	0.000213	0.00198	CcSEcCtD
Erythromycin—Convulsion—Epirubicin—uterine cancer	0.000209	0.00194	CcSEcCtD
Erythromycin—Nausea—Etoposide—uterine cancer	0.000209	0.00194	CcSEcCtD
Erythromycin—Chest pain—Epirubicin—uterine cancer	0.000206	0.00191	CcSEcCtD
Erythromycin—Discomfort—Epirubicin—uterine cancer	0.000203	0.00188	CcSEcCtD
Erythromycin—Vertigo—Doxorubicin—uterine cancer	0.000201	0.00186	CcSEcCtD
Erythromycin—ABCB1—female gonad—uterine cancer	0.000199	0.00848	CbGeAlD
Erythromycin—Confusional state—Epirubicin—uterine cancer	0.000199	0.00184	CcSEcCtD
Erythromycin—ABCB1—vagina—uterine cancer	0.000198	0.00843	CbGeAlD
Erythromycin—Palpitations—Doxorubicin—uterine cancer	0.000197	0.00183	CcSEcCtD
Erythromycin—Anaphylactic shock—Epirubicin—uterine cancer	0.000197	0.00183	CcSEcCtD
Erythromycin—Convulsion—Doxorubicin—uterine cancer	0.000194	0.00179	CcSEcCtD
Erythromycin—Chest pain—Doxorubicin—uterine cancer	0.00019	0.00176	CcSEcCtD
Erythromycin—Discomfort—Doxorubicin—uterine cancer	0.000188	0.00174	CcSEcCtD
Erythromycin—Anorexia—Epirubicin—uterine cancer	0.000188	0.00174	CcSEcCtD
Erythromycin—Confusional state—Doxorubicin—uterine cancer	0.000184	0.0017	CcSEcCtD
Erythromycin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000182	0.00169	CcSEcCtD
Erythromycin—Anorexia—Doxorubicin—uterine cancer	0.000174	0.00161	CcSEcCtD
Erythromycin—Decreased appetite—Epirubicin—uterine cancer	0.000171	0.00159	CcSEcCtD
Erythromycin—Pain—Epirubicin—uterine cancer	0.000168	0.00156	CcSEcCtD
Erythromycin—Feeling abnormal—Epirubicin—uterine cancer	0.000162	0.00151	CcSEcCtD
Erythromycin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000161	0.00149	CcSEcCtD
Erythromycin—Decreased appetite—Doxorubicin—uterine cancer	0.000158	0.00147	CcSEcCtD
Erythromycin—Urticaria—Epirubicin—uterine cancer	0.000157	0.00145	CcSEcCtD
Erythromycin—Pain—Doxorubicin—uterine cancer	0.000156	0.00145	CcSEcCtD
Erythromycin—Abdominal pain—Epirubicin—uterine cancer	0.000156	0.00144	CcSEcCtD
Erythromycin—Feeling abnormal—Doxorubicin—uterine cancer	0.00015	0.00139	CcSEcCtD
Erythromycin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000149	0.00138	CcSEcCtD
Erythromycin—Hypersensitivity—Epirubicin—uterine cancer	0.000145	0.00135	CcSEcCtD
Erythromycin—Urticaria—Doxorubicin—uterine cancer	0.000145	0.00134	CcSEcCtD
Erythromycin—Abdominal pain—Doxorubicin—uterine cancer	0.000144	0.00134	CcSEcCtD
Erythromycin—Pruritus—Epirubicin—uterine cancer	0.000139	0.00129	CcSEcCtD
Erythromycin—Diarrhoea—Epirubicin—uterine cancer	0.000135	0.00125	CcSEcCtD
Erythromycin—Hypersensitivity—Doxorubicin—uterine cancer	0.000134	0.00125	CcSEcCtD
Erythromycin—Dizziness—Epirubicin—uterine cancer	0.00013	0.00121	CcSEcCtD
Erythromycin—Pruritus—Doxorubicin—uterine cancer	0.000129	0.0012	CcSEcCtD
Erythromycin—ABCB1—lymph node—uterine cancer	0.000128	0.00545	CbGeAlD
Erythromycin—Vomiting—Epirubicin—uterine cancer	0.000125	0.00116	CcSEcCtD
Erythromycin—Diarrhoea—Doxorubicin—uterine cancer	0.000125	0.00116	CcSEcCtD
Erythromycin—Rash—Epirubicin—uterine cancer	0.000124	0.00115	CcSEcCtD
Erythromycin—Dizziness—Doxorubicin—uterine cancer	0.000121	0.00112	CcSEcCtD
Erythromycin—Nausea—Epirubicin—uterine cancer	0.000117	0.00109	CcSEcCtD
Erythromycin—Vomiting—Doxorubicin—uterine cancer	0.000116	0.00107	CcSEcCtD
Erythromycin—Rash—Doxorubicin—uterine cancer	0.000115	0.00107	CcSEcCtD
Erythromycin—Nausea—Doxorubicin—uterine cancer	0.000108	0.001	CcSEcCtD
Erythromycin—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	3.48e-05	0.0026	CbGpPWpGaD
Erythromycin—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	3.46e-05	0.00259	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SMAD3—uterine cancer	3.38e-05	0.00253	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—NDUFB11—uterine cancer	3.33e-05	0.00249	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—SRD5A2—uterine cancer	3.33e-05	0.00249	CbGpPWpGaD
Erythromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	3.29e-05	0.00245	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CXCL8—uterine cancer	3.25e-05	0.00243	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.23e-05	0.00241	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—FGFR2—uterine cancer	3.23e-05	0.00241	CbGpPWpGaD
Erythromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.07e-05	0.0023	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	3.05e-05	0.00228	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.05e-05	0.00228	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NDUFB11—uterine cancer	2.99e-05	0.00224	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—SRD5A2—uterine cancer	2.99e-05	0.00224	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.91e-05	0.00217	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.9e-05	0.00216	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	2.88e-05	0.00215	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	2.84e-05	0.00212	CbGpPWpGaD
Erythromycin—ABCC1—Disease—AKR1B10—uterine cancer	2.78e-05	0.00208	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ESR1—uterine cancer	2.76e-05	0.00206	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	2.76e-05	0.00206	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	2.76e-05	0.00206	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.75e-05	0.00205	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.69e-05	0.00201	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.68e-05	0.00201	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	2.68e-05	0.002	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NDUFB11—uterine cancer	2.61e-05	0.00195	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—SRD5A2—uterine cancer	2.61e-05	0.00195	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—NRAS—uterine cancer	2.61e-05	0.00195	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.55e-05	0.00191	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.44e-05	0.00182	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCL2—uterine cancer	2.43e-05	0.00182	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	2.42e-05	0.00181	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	2.42e-05	0.00181	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—STAR—uterine cancer	2.41e-05	0.0018	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AKR1B1—uterine cancer	2.41e-05	0.0018	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.38e-05	0.00178	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.36e-05	0.00176	CbGpPWpGaD
Erythromycin—ABCC1—Disease—RNF43—uterine cancer	2.3e-05	0.00172	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.3e-05	0.00172	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.29e-05	0.00171	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.27e-05	0.0017	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—PIK3CA—uterine cancer	2.27e-05	0.0017	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.27e-05	0.00169	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—KRAS—uterine cancer	2.25e-05	0.00168	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.22e-05	0.00166	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.2e-05	0.00164	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.19e-05	0.00164	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.19e-05	0.00163	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—STAR—uterine cancer	2.16e-05	0.00162	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AKR1B1—uterine cancer	2.16e-05	0.00162	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.15e-05	0.00161	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.14e-05	0.0016	CbGpPWpGaD
Erythromycin—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.12e-05	0.00158	CbGpPWpGaD
Erythromycin—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.09e-05	0.00156	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.07e-05	0.00154	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—PIK3CA—uterine cancer	2.06e-05	0.00154	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—ERBB2—uterine cancer	2.03e-05	0.00151	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	1.95e-05	0.00146	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—SRD5A2—uterine cancer	1.93e-05	0.00144	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NDUFB11—uterine cancer	1.93e-05	0.00144	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL8—uterine cancer	1.92e-05	0.00144	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—HRAS—uterine cancer	1.91e-05	0.00143	CbGpPWpGaD
Erythromycin—ABCC1—Disease—AKR1C1—uterine cancer	1.9e-05	0.00142	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—STAR—uterine cancer	1.89e-05	0.00141	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.89e-05	0.00141	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.89e-05	0.00141	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—POLD1—uterine cancer	1.89e-05	0.00141	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.89e-05	0.00141	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CDKN1B—uterine cancer	1.88e-05	0.0014	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.87e-05	0.00139	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—AKT1—uterine cancer	1.86e-05	0.00139	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.85e-05	0.00138	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.85e-05	0.00138	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CTNNB1—uterine cancer	1.77e-05	0.00132	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AKR1C1—uterine cancer	1.77e-05	0.00132	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PTEN—uterine cancer	1.73e-05	0.00129	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—POLD1—uterine cancer	1.7e-05	0.00127	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—AKT1—uterine cancer	1.69e-05	0.00126	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.66e-05	0.00124	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EP300—uterine cancer	1.65e-05	0.00123	CbGpPWpGaD
Erythromycin—ABCC1—Disease—DCN—uterine cancer	1.64e-05	0.00123	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.63e-05	0.00122	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.63e-05	0.00122	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.61e-05	0.0012	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AKR1C1—uterine cancer	1.59e-05	0.00119	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—RRM2—uterine cancer	1.57e-05	0.00118	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—VEGFA—uterine cancer	1.56e-05	0.00117	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NRAS—uterine cancer	1.54e-05	0.00115	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—DCN—uterine cancer	1.53e-05	0.00114	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—POLD1—uterine cancer	1.48e-05	0.00111	CbGpPWpGaD
Erythromycin—ABCC1—Disease—AKR1C3—uterine cancer	1.46e-05	0.00109	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP11A1—uterine cancer	1.44e-05	0.00108	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NDUFB11—uterine cancer	1.42e-05	0.00106	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SRD5A2—uterine cancer	1.42e-05	0.00106	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HMGA1—uterine cancer	1.42e-05	0.00106	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—RRM2—uterine cancer	1.42e-05	0.00106	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.4e-05	0.00104	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—STAR—uterine cancer	1.4e-05	0.00104	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AKR1C1—uterine cancer	1.39e-05	0.00104	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—DCN—uterine cancer	1.37e-05	0.00103	CbGpPWpGaD
Erythromycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.37e-05	0.00103	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.36e-05	0.00102	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—STAR—uterine cancer	1.36e-05	0.00102	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AKR1C3—uterine cancer	1.36e-05	0.00102	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.35e-05	0.00101	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—KRAS—uterine cancer	1.33e-05	0.000991	CbGpPWpGaD
Erythromycin—ABCC1—Disease—FBXW7—uterine cancer	1.3e-05	0.000972	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP11A1—uterine cancer	1.3e-05	0.000967	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—RRM2—uterine cancer	1.24e-05	0.000923	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AKR1C3—uterine cancer	1.22e-05	0.000914	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—PIK3CA—uterine cancer	1.22e-05	0.000911	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—DCN—uterine cancer	1.2e-05	0.000896	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.19e-05	0.000893	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—uterine cancer	1.18e-05	0.000881	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.14e-05	0.000849	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.14e-05	0.000849	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP11A1—uterine cancer	1.13e-05	0.000844	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HRAS—uterine cancer	1.13e-05	0.000843	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.11e-05	0.000827	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.1e-05	0.000825	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—POLD1—uterine cancer	1.1e-05	0.000818	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—POLD1—uterine cancer	1.07e-05	0.0008	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.07e-05	0.000797	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—STK11—uterine cancer	1.06e-05	0.000791	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CYP19A1—uterine cancer	1.06e-05	0.000791	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.05e-05	0.000781	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.04e-05	0.000779	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—STAR—uterine cancer	1.03e-05	0.000769	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AKR1B1—uterine cancer	1.03e-05	0.000769	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.02e-05	0.000765	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CDKN2B—uterine cancer	1.02e-05	0.000762	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.02e-05	0.000761	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AKR1C1—uterine cancer	1e-05	0.000748	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—AKT1—uterine cancer	9.96e-06	0.000744	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.94e-06	0.000742	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	9.72e-06	0.000726	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—STK11—uterine cancer	9.53e-06	0.000712	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CYP19A1—uterine cancer	9.53e-06	0.000712	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.48e-06	0.000708	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SMAD3—uterine cancer	9.31e-06	0.000696	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.2e-06	0.000688	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—RRM2—uterine cancer	9.13e-06	0.000682	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.94e-06	0.000668	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—RRM2—uterine cancer	8.93e-06	0.000667	CbGpPWpGaD
Erythromycin—ABCC1—Disease—FGFR2—uterine cancer	8.88e-06	0.000663	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—DCN—uterine cancer	8.87e-06	0.000662	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NDUFB11—uterine cancer	8.78e-06	0.000655	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SRD5A2—uterine cancer	8.78e-06	0.000655	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—DCN—uterine cancer	8.67e-06	0.000647	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MTHFR—uterine cancer	8.55e-06	0.000639	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.53e-06	0.000637	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP11A1—uterine cancer	8.35e-06	0.000624	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—STK11—uterine cancer	8.31e-06	0.000621	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CYP19A1—uterine cancer	8.31e-06	0.000621	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AKR1B1—uterine cancer	8.22e-06	0.000614	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—STAR—uterine cancer	8.22e-06	0.000614	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP11A1—uterine cancer	8.17e-06	0.00061	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.13e-06	0.000607	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—POLD1—uterine cancer	8.08e-06	0.000604	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—MTHFR—uterine cancer	7.96e-06	0.000594	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AKR1C3—uterine cancer	7.89e-06	0.000589	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.82e-06	0.000584	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AKR1C3—uterine cancer	7.71e-06	0.000576	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AKR1C1—uterine cancer	7.56e-06	0.000565	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.19e-06	0.000537	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—MTHFR—uterine cancer	7.16e-06	0.000535	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.01e-06	0.000524	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.95e-06	0.000519	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—RRM2—uterine cancer	6.74e-06	0.000503	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—DCN—uterine cancer	6.54e-06	0.000489	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—POLD1—uterine cancer	6.45e-06	0.000482	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.34e-06	0.000474	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—STAR—uterine cancer	6.34e-06	0.000474	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.31e-06	0.000471	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—MTHFR—uterine cancer	6.24e-06	0.000466	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP11A1—uterine cancer	6.16e-06	0.00046	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—STK11—uterine cancer	6.15e-06	0.000459	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP19A1—uterine cancer	6.15e-06	0.000459	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AKR1C1—uterine cancer	6.03e-06	0.000451	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—STK11—uterine cancer	6.01e-06	0.000449	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP19A1—uterine cancer	6.01e-06	0.000449	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.87e-06	0.000439	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AKR1C3—uterine cancer	5.82e-06	0.000435	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ERBB2—uterine cancer	5.58e-06	0.000417	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—RRM2—uterine cancer	5.38e-06	0.000402	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—DCN—uterine cancer	5.22e-06	0.00039	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CDKN1B—uterine cancer	5.17e-06	0.000386	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—POLD1—uterine cancer	4.98e-06	0.000372	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP11A1—uterine cancer	4.92e-06	0.000367	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CTNNB1—uterine cancer	4.88e-06	0.000365	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTEN—uterine cancer	4.76e-06	0.000355	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.66e-06	0.000348	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AKR1C3—uterine cancer	4.64e-06	0.000347	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—MTHFR—uterine cancer	4.62e-06	0.000345	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EP300—uterine cancer	4.54e-06	0.000339	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—STK11—uterine cancer	4.53e-06	0.000339	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP19A1—uterine cancer	4.53e-06	0.000339	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—MTHFR—uterine cancer	4.51e-06	0.000337	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTEN—uterine cancer	4.43e-06	0.000331	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NRAS—uterine cancer	4.24e-06	0.000317	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—EP300—uterine cancer	4.22e-06	0.000315	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—RRM2—uterine cancer	4.15e-06	0.00031	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—DCN—uterine cancer	4.03e-06	0.000301	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTEN—uterine cancer	3.98e-06	0.000298	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—EP300—uterine cancer	3.8e-06	0.000284	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.8e-06	0.000284	CbGpPWpGaD
Erythromycin—ABCC1—Disease—KRAS—uterine cancer	3.65e-06	0.000273	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—STK11—uterine cancer	3.62e-06	0.00027	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.62e-06	0.00027	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.58e-06	0.000268	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTEN—uterine cancer	3.47e-06	0.00026	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—MTHFR—uterine cancer	3.41e-06	0.000254	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.4e-06	0.000254	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PIK3CA—uterine cancer	3.36e-06	0.000251	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—EP300—uterine cancer	3.31e-06	0.000247	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.24e-06	0.000242	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PIK3CA—uterine cancer	3.12e-06	0.000233	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HRAS—uterine cancer	3.1e-06	0.000232	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PIK3CA—uterine cancer	2.81e-06	0.00021	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—STK11—uterine cancer	2.79e-06	0.000209	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.79e-06	0.000209	CbGpPWpGaD
Erythromycin—ABCC1—Disease—AKT1—uterine cancer	2.74e-06	0.000205	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—MTHFR—uterine cancer	2.72e-06	0.000203	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTEN—uterine cancer	2.57e-06	0.000192	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—AKT1—uterine cancer	2.55e-06	0.000191	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTEN—uterine cancer	2.51e-06	0.000188	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PIK3CA—uterine cancer	2.45e-06	0.000183	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—EP300—uterine cancer	2.45e-06	0.000183	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.4e-06	0.000179	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—EP300—uterine cancer	2.39e-06	0.000179	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—AKT1—uterine cancer	2.3e-06	0.000171	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—MTHFR—uterine cancer	2.1e-06	0.000157	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—AKT1—uterine cancer	2e-06	0.00015	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTEN—uterine cancer	1.89e-06	0.000142	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.81e-06	0.000135	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—EP300—uterine cancer	1.81e-06	0.000135	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.77e-06	0.000132	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTEN—uterine cancer	1.51e-06	0.000113	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—AKT1—uterine cancer	1.48e-06	0.000111	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—AKT1—uterine cancer	1.45e-06	0.000108	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—EP300—uterine cancer	1.44e-06	0.000108	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PIK3CA—uterine cancer	1.34e-06	9.99e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTEN—uterine cancer	1.17e-06	8.72e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—EP300—uterine cancer	1.11e-06	8.32e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—AKT1—uterine cancer	1.09e-06	8.16e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.07e-06	7.97e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—AKT1—uterine cancer	8.72e-07	6.51e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PIK3CA—uterine cancer	8.24e-07	6.15e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—AKT1—uterine cancer	6.73e-07	5.03e-05	CbGpPWpGaD
